BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 23, 2004
View Archived Issues
Small-molecule CFTR inhibitor for prevention of toxin-induced secretory diarrhea
Read More
In vivo antichlolesterolemic effects of fungal Beauveriolides I and III
Read More
Vitamin D synthesis reduced following burn injuries
Read More
Sildenafil in pulmonary arterial hypertension
Read More
Genmab highlights many accomplishments during 2003
Read More
Significant improvements found with ropinirole in restless legs syndrome
Read More
Draxis Health updates radiopharmaceuticals business
Read More
Novartis terminates PDI sales contract
Read More
Ark to float on London SE; four lead products in pipeline
Read More
Small-molecule EPO receptor modulators newly identified at Receptron
Read More
New anti-HCV agents described by researchers at K.U. Leuven and Gilead
Read More
BMS researchers claim novel agents for diabetes and obesity
Read More
Novel PDE4 inhibitors and their use described by Merck Frosst scientists
Read More
New PPARalpha/PPARgamma agonists in early development at Roche
Read More
Indian researchers prepare and test novel HMG-CoA reductase inhibitors
Read More
New NADPH oxidase inhibitors and their use in arthritis and Alzheimer's disease
Read More
Additional data on the safety and antiretroviral efficacy of enfuvirtide
Read More
First data on the safety and pharmacokinetics of the novel antiretroviral GW-873140
Read More
Strong antiviral effects reported for Reverset(TM) in treatment-naive HIV patients
Read More
Promising phase II results found for PCK-3145 in advanced prostate cancer
Read More
Discovery Partners signs new chemistry agreement with Pfizer
Read More
Rivex Pharma and Anika extend Canadian Orthovisc distribution agreement
Read More
Arilvax BLA temporarily withdrawn
Read More
Positive opinions for Promixin
Read More
Enrollment completed in REALITY stent trial
Read More
Australian Government grant supports advancement of PBT-2
Read More
Exelixis files IND for XL-647
Read More
Second phase III safety study of SPI-0211 confirms earlier positive results
Read More
NexMed licenses Femprox to CJ for Korea
Read More
Enrollment scheduled to conclude in pivotal MyVax trial
Read More
Clinical trial of ANA-971, oral prodrug of isatoribine
Read More
NovoSeven approved in Europe for factor VII deficiency and thrombasthenia
Read More